Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Artificial intelligence: where do we begin? Do we start with the data, or do we start by reinventing our processes?

In theory, the path forward is clear: interoperability, data-driven manufacturing, and smarter scheduling powered by AI. Imagine simply inputting what you want to make — dimensions, material — and the ...

Supply Chain Management Review, reposted here, a Rutgers Business School graduate student (Master of Supply Chain Analytics) explains how as disruptions become structural rather than episodic, ...

Automakers face higher costs from US port fees, car carrier Wallenius Wilhelmsen warns Automakers transporting their cars to the U.S. could face $200 to $300 per vehicle in additional costs, the CEO ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...